Two-week direct-acting antiviral prophylaxis prevents hep C after kidney transplant
Two-week direct-acting antiviral (DAA) prophylaxis prevents hepatitis C virus (HCV) infection in individuals without HCV viremia who received kidney transplant (KT) from donors with HCV viremia (HCV D+/R−), according to ...
Nov 28, 2023
0
1